Zhongchao Inc. (ZCMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
ZCMD POWR Grades
- Value is the dimension where ZCMD ranks best; there it ranks ahead of 82.58% of US stocks.
- ZCMD's strongest trending metric is Momentum; it's been moving down over the last 33 weeks.
- ZCMD ranks lowest in Growth; there it ranks in the 21st percentile.
ZCMD Stock Summary
- ZCMD's went public 1.65 years ago, making it older than merely 2.26% of listed US stocks we're tracking.
- For ZCMD, its debt to operating expenses ratio is greater than that reported by merely 5.5% of US equities we're observing.
- With a year-over-year growth in debt of -91.45%, Zhongchao Inc's debt growth rate surpasses only 2.55% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Zhongchao Inc are BRC, JOUT, IOSP, ISDR, and MLHR.
- ZCMD's SEC filings can be seen here. And to visit Zhongchao Inc's official web site, go to www.izcmd.com.
ZCMD Valuation Summary
- ZCMD's price/sales ratio is 2.5; this is 52.83% lower than that of the median Technology stock.
- ZCMD's EV/EBIT ratio has moved down 20.6 over the prior 18 months.
- ZCMD's price/sales ratio has moved down 5.3 over the prior 18 months.
Below are key valuation metrics over time for ZCMD.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| ZCMD | 2021-09-01 | 2.5 | 1.4 | 10.0 | 5.9 |
| ZCMD | 2021-08-31 | 2.5 | 1.4 | 10.1 | 6.0 |
| ZCMD | 2021-08-30 | 2.5 | 1.4 | 10.0 | 5.9 |
| ZCMD | 2021-08-27 | 2.5 | 1.4 | 10.0 | 5.9 |
| ZCMD | 2021-08-26 | 2.5 | 1.4 | 9.9 | 5.9 |
| ZCMD | 2021-08-25 | 2.5 | 1.4 | 10.0 | 5.9 |
ZCMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ZCMD has a Quality Grade of C, ranking ahead of 45.59% of graded US stocks.
- ZCMD's asset turnover comes in at 0.685 -- ranking 24th of 51 Personal Services stocks.
- 500 - Internal server error
The table below shows ZCMD's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2020-12-31 | 0.685 | 0.660 | 0.409 |
| 2020-12-31 | 0.685 | 0.660 | 0.409 |
| 2019-12-31 | 0.937 | 0.687 | 0.772 |
ZCMD Stock Price Chart Interactive Chart >
ZCMD Price/Volume Stats
| Current price | $1.73 | 52-week high | $4.09 |
| Prev. close | $1.67 | 52-week low | $1.46 |
| Day low | $1.68 | Volume | 16,400 |
| Day high | $1.74 | Avg. volume | 988,364 |
| 50-day MA | $1.64 | Dividend yield | N/A |
| 200-day MA | $1.80 | Market Cap | 31.29M |
Zhongchao Inc. (ZCMD) Company Bio
Zhongchao, Inc. is a holding company that engages in the provision of healthcare information, education, and training services. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference & workshops, continuing education courses, articles & short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on April 16, 2019 and is headquartered in Shanghai, China.
Latest ZCMD News From Around the Web
Below are the latest news stories about Zhongchao Inc that investors may wish to consider to help them evaluate ZCMD as an investment opportunity.
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and TreatmentZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced the launch of its multidisciplinary treatment ("MDT") clinical thinking training platform for hematology ("Hematology MDT Platform"). The Hematology MDT Platform provides clinicians with a channel to learn multidisciplin |
Can Zhongchao Inc. (NASDAQ:ZCMD) Maintain Its Strong Returns?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is... |
Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital MarketZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") launches Hematological Tumor Patient Care Center (the "Care Center"), continuing to improve its business ecology in tumor patient management and |
Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer MarketZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") provides patient follow-up management services for ovarian cancer patients from Zeyoulexiang Patient Assistance Project (the "Project"), helping |
Zhongchao Inc. Builds A Patient DOT Management SystemZhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") launches Treatment Outcome Oriented DOT Management System ("DOT Management System") to accelerate the development of patient management business, meeting the increasing demand in tumor and rare disease pa |
ZCMD Price Returns
| 1-mo | 10.90% |
| 3-mo | 4.22% |
| 6-mo | -4.31% |
| 1-year | -6.99% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 1.76% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...